The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 07, 2021

Filed:

Feb. 11, 2019
Applicants:

Public University Corporation Yokohama City University, Yokohama, JP;

Tosoh Corporation, Shunan, JP;

Inventors:

Noriaki Arakawa, Yokohama, JP;

Hisashi Hirano, Yokohama, JP;

Etsuko Miyagi, Yokohama, JP;

Norihisa Ohtake, Ayase, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/574 (2006.01); C07K 16/38 (2006.01); C07K 14/47 (2006.01); C12N 15/09 (2006.01); G01N 27/62 (2021.01); C07K 14/81 (2006.01);
U.S. Cl.
CPC ...
G01N 33/57449 (2013.01); C07K 14/47 (2013.01); C07K 14/8114 (2013.01); C07K 16/38 (2013.01); C12N 15/09 (2013.01); G01N 27/62 (2013.01); G01N 33/574 (2013.01); G01N 2333/8114 (2013.01);
Abstract

The present invention aims to provide a method for detecting, with high sensitivity and specificity, ovarian clear cell adenocarcinoma, which is highly malignant, among benign and malignant ovarian tumors having various tissue types, and a reagent that can be used for the method. The present invention provides NT-TFPI2, which is a novel processed tissue factor pathway inhibitor 2 polypeptide, as a new detection marker for ovarian clear cell adenocarcinoma. The detection of ovarian clear cell adenocarcinoma is carried out by measuring the amount of NT-TFPI2, or the total amount of NT-TFPI2 and intact TFPI2. The reagent for detecting ovarian clear cell adenocarcinoma contains an antibody that specifically recognizes NT-TFPI2 and intact TFPI2.


Find Patent Forward Citations

Loading…